title: Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.
abstract: OBJECTIVE
  CXC chemokine receptor 4 (CXCR4) and vascular endothelial growth factor (VEGF) are implicated in the metastatic process of malignant tumors. However, no data are currently available on the biological relationship between these molecules in colorectal cancer. We studied whether CXCR4 and VEGF expression could predict relapse and evaluated in vitro the contribution of CXCR4 in promoting clonogenic growth, VEGF secretion, and intercellular adhesion molecule-1 (ICAM-1) expression of colorectal cancer cells.
  
  
  METHODS
  CXCR4 and VEGF were studied in colorectal cancer tissues and in Lovo, HT29, and SW620 colorectal cancer cell lines by immunohistochemistry. Correlations with baseline characteristics of patients and tumors were analyzed by chi2 test. VEGF secretion induced by CXCL12 was measured by ELISA. The effect of CXCL12 on ICAM-1 expression was evaluated by flow cytometry. Clonogenic growth induced by CXCL12 was determined by clonogenic assays. Functional effects induced by CXCL12 were prevented by the administration in vitro of AMD3100, a bicyclam noncompetitive antagonist of CXCR4.
  
  
  RESULTS
  Seventy-two patients, seen between January 2003 and January 2004, were studied. CXCR4 was absent in 16 tumors (22.2%); it was expressed in < or = 50% of cells in 25 (34.7%) tumors and in >50% of cells in 31 (43.0%) tumors. VEGF was absent in 17 (23.6%) tumors; it was expressed in < or = 50% of cells in 16 (22.2%) tumors and in >50% of cells in 39 (54.2%) tumors. There was a significant association between CXCR4 expression and lymph nodal status (P = 0.0393). There were significant associations between VEGF and tumor invasion (P = 0.0386) and lymph nodal involvement (P = 0.0044). American Joint Committee on Cancer stage (P = 0.0016), VEGF expression (P = 0.0450), CXCR4 expression (P = 0.0428), and VEGF/CXCR4 expression (P = 0.0004) had a significant prognostic value for disease-free survival with univariate analysis. The predictive ability of the American Joint Committee on Cancer stage and of the concomitant and high expression of VEGF and CXCR4 was confirmed by multivariate analysis. Prognosis is particularly unfavorable for patients whose primary tumors express CXCR4 and VEGF in >50% of cells (median disease-free survival in relapsed patients, 5.8 months; hazard ratio of relapse, 8.23; 95% confidence interval, 7.24-14.29). In clonogenic assays, CXCL12 (20 ng/mL/d) significantly increased the number of clones in SW620, HT29, and Lovo cells at 7 and 14 days. Again, CXCL12 was able to stimulate VEGF secretion in SW620, HT29, and Lovo cells as well as up-regulated ICAM-1. These effects were prevented by the administration of AMD3100 (1 micromol/L).
  
  
  CONCLUSIONS
  We have shown that concomitant and high expression of CXCR4 and VEGF is a strong and independent predictor of early distant relapse in colorectal cancer. CXCR4 triggers a plethora of phenomena, including stimulation of clonogenic growth, induction of VEGF release, and ICAM-1 up-regulation. These data support the inhibition of CXCR4 to prevent the development of colorectal cancer metastasis.
authors: Department of Clinical Immunology, National Cancer Institute, G. Pascale Foundation, Naples, Italy. ale.otto@libero.it
authors: Alessandro
authors: A
authors: Ottaiano
authors: Renato
authors: R
authors: Franco
authors: Annarita
authors: A
authors: Aiello Talamanca
authors: Giuseppina
authors: G
authors: Liguori
authors: Fabiana
authors: F
authors: Tatangelo
authors: Paolo
authors: P
authors: Delrio
authors: Guglielmo
authors: G
authors: Nasti
authors: Emiddio
authors: E
authors: Barletta
authors: Gaetano
authors: G
authors: Facchini
authors: Bruno
authors: B
authors: Daniele
authors: Arturo
authors: A
authors: Di Blasi
authors: Maria
authors: M
authors: Napolitano
authors: Caterina
authors: C
authors: Ieranò
authors: Rosa
authors: R
authors: Calemma
authors: Enrico
authors: E
authors: Leonardi
authors: Vittorio
authors: V
authors: Albino
authors: Valentina
authors: V
authors: De Angelis
authors: Marzia
authors: M
authors: Falanga
authors: Vincenzo
authors: V
authors: Boccia
authors: Maurizio
authors: M
authors: Capuozzo
authors: Valerio
authors: V
authors: Parisi
authors: Gerardo
authors: G
authors: Botti
authors: Giuseppe
authors: G
authors: Castello
authors: Rosario
authors: R
authors: Vincenzo Iaffaioli
authors: Stefania
authors: S
authors: Scala